|
| 维力医疗(603309)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2024-12-16 | 102.00 | 0.35% | 29316.02 | 0.00 | 29107.22 | 99.29% | 股权激励限售股份 | | 2024-11-25 | 3.30 | 0.01% | 29217.92 | 98.10 | 29102.82 | 99.27% | 股权激励限售股份 | | 2023-12-01 | 4.40 | 0.02% | 29107.22 | 208.80 | 29102.82 | 99.27% | 股权激励限售股份 | | 2023-04-28 | 139.60 | 0.48% | 29102.82 | 229.40 | 28963.22 | 98.74% | 股权激励限售股份 | | 2022-07-11 | 2963.22 | 10.10% | 28963.22 | 379.00 | 28963.22 | 98.71% | 定向增发机构配售股份 | | 2018-03-02 | 12300.00 | 61.50% | 20000.00 | 0.00 | 20000.00 | 100.00% | 发行前股份限售流通 | | 2016-03-02 | 2700.00 | 13.50% | 7700.00 | 12300.00 | 20000.00 | 100.00% | 发行前股份限售流通 |
|